NO941415L - - Google Patents
Info
- Publication number
- NO941415L NO941415L NO941415A NO941415A NO941415L NO 941415 L NO941415 L NO 941415L NO 941415 A NO941415 A NO 941415A NO 941415 A NO941415 A NO 941415A NO 941415 L NO941415 L NO 941415L
- Authority
- NO
- Norway
- Prior art keywords
- mbp
- residues
- amino acid
- synthetic peptides
- peptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Zoology (AREA)
- Rehabilitation Therapy (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002053799A CA2053799C (fr) | 1991-10-22 | 1991-10-22 | Specificite pour les peptides synthetiques de la proteine basique anti-myeline presente dans le liquide cephalorachidien de patients atteints de la sclerose en plaques |
PCT/CA1992/000448 WO1993008212A1 (fr) | 1991-10-22 | 1992-10-15 | Specificite de peptides synthetiques de proteines de base anti-myeline provenant du liquide cephalo-rachidien d'un individu souffrant de sclerose multiple |
Publications (3)
Publication Number | Publication Date |
---|---|
NO941415D0 NO941415D0 (no) | 1994-04-19 |
NO941415L true NO941415L (fr) | 1994-06-22 |
NO310513B1 NO310513B1 (no) | 2001-07-16 |
Family
ID=4148603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19941415A NO310513B1 (no) | 1991-10-22 | 1994-04-19 | Farmasöytisk preparat inneholdende et peptid som aktiv bestanddel, og anvendelse av et peptid for fremstilling av etmedikament for behandling av multippel sklerose |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0610446B1 (fr) |
AT (1) | ATE236193T1 (fr) |
AU (1) | AU2750092A (fr) |
CA (1) | CA2053799C (fr) |
DE (1) | DE69232987T2 (fr) |
DK (1) | DK0610446T3 (fr) |
ES (1) | ES2196007T3 (fr) |
FI (1) | FI111050B (fr) |
NO (1) | NO310513B1 (fr) |
NZ (1) | NZ244807A (fr) |
RU (1) | RU2121850C1 (fr) |
WO (1) | WO1993008212A1 (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5817629A (en) * | 1991-10-22 | 1998-10-06 | The Governors Of The University Of Alberta | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
US6252040B1 (en) * | 1991-10-22 | 2001-06-26 | The Governors Of The University Of Alberta | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
EP0787147A1 (fr) * | 1994-10-25 | 1997-08-06 | Immulogic Pharmaceutical Corporation | Compositions et traitement pour la sclerose en plaques |
CA2205532A1 (fr) | 1994-11-18 | 1996-05-30 | Neurocrine Biosciences, Inc. | Methodes de traitement de la sclerose en plaques par l'emploi d'analogues peptidiques a la position 91 de la proteine basique de la myeline humaine |
US6251396B1 (en) | 1994-11-18 | 2001-06-26 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
US6379670B1 (en) | 1994-11-18 | 2002-04-30 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
US6329499B1 (en) * | 1994-11-18 | 2001-12-11 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein |
WO1996028470A2 (fr) * | 1995-03-09 | 1996-09-19 | Neurocrine Biosciences, Inc. | Analogues peptidiques de proteine de base de myeline utile dans le traitement de la sclerose en plaques |
CA2201841C (fr) * | 1997-04-04 | 2010-01-26 | The Governors Of The University Of Alberta | Specificite des peptides de la proteine basique anti-myeline et administration de ces peptides aux patients atteints de sclerose en plaques |
WO2005009455A1 (fr) * | 2003-07-29 | 2005-02-03 | Terentiev Alexandr Alexandrovi | Composition de peptides presentant une propriete immunoregulatrice |
CN102781465A (zh) | 2009-10-12 | 2012-11-14 | 生命生物实验室有限公司 | 用于治疗多发性硬化的组合物 |
US9326773B2 (en) | 2012-01-26 | 2016-05-03 | Covidien Lp | Surgical device including buttress material |
WO2024094562A1 (fr) * | 2022-11-01 | 2024-05-10 | Universität Zürich | Nouveaux peptides mbp et leur utilisation dans le traitement de la sclérose en plaques |
-
1991
- 1991-10-22 CA CA002053799A patent/CA2053799C/fr not_active Expired - Lifetime
-
1992
- 1992-10-15 WO PCT/CA1992/000448 patent/WO1993008212A1/fr active Search and Examination
- 1992-10-15 DE DE69232987T patent/DE69232987T2/de not_active Expired - Lifetime
- 1992-10-15 DK DK93908754T patent/DK0610446T3/da active
- 1992-10-15 RU RU94027578A patent/RU2121850C1/ru not_active IP Right Cessation
- 1992-10-15 AT AT93908754T patent/ATE236193T1/de not_active IP Right Cessation
- 1992-10-15 ES ES93908754T patent/ES2196007T3/es not_active Expired - Lifetime
- 1992-10-15 EP EP93908754A patent/EP0610446B1/fr not_active Expired - Lifetime
- 1992-10-15 AU AU27500/92A patent/AU2750092A/en not_active Abandoned
- 1992-10-20 NZ NZ244807A patent/NZ244807A/xx not_active IP Right Cessation
-
1994
- 1994-04-19 NO NO19941415A patent/NO310513B1/no not_active IP Right Cessation
- 1994-04-21 FI FI941860A patent/FI111050B/fi active
Also Published As
Publication number | Publication date |
---|---|
FI941860A (fi) | 1994-04-21 |
DE69232987D1 (de) | 2003-05-08 |
DE69232987T2 (de) | 2004-01-29 |
ES2196007T3 (es) | 2003-12-16 |
RU94027578A (ru) | 1996-10-20 |
FI111050B (fi) | 2003-05-30 |
NZ244807A (en) | 1997-08-22 |
CA2053799A1 (fr) | 1993-04-23 |
AU2750092A (en) | 1993-05-21 |
WO1993008212A1 (fr) | 1993-04-29 |
NO310513B1 (no) | 2001-07-16 |
EP0610446A1 (fr) | 1994-08-17 |
ATE236193T1 (de) | 2003-04-15 |
FI941860A0 (fi) | 1994-04-21 |
CA2053799C (fr) | 2002-03-12 |
NO941415D0 (no) | 1994-04-19 |
DK0610446T3 (da) | 2003-07-14 |
RU2121850C1 (ru) | 1998-11-20 |
EP0610446B1 (fr) | 2003-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68916932D1 (de) | Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus. | |
MX9703643A (es) | Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana. | |
NO941415L (fr) | ||
ES2178000T3 (es) | Composiciones y metodos para tratar infecciones usando analogos de indolicidina. | |
WO1996028470A3 (fr) | Analogues peptidiques de proteine de base de myeline utile dans le traitement de la sclerose en plaques | |
HUT62916A (en) | Process for producing immunogenic peptides and pharmaceutical compositions comprising same | |
MX9703642A (es) | Metodos para el tratamiento de esclerosis multiple utilizando analogos de peptido en la posicion 91 de la proteina basica de mielina humana. | |
NZ293910A (en) | Peptides useful in immunoregulation of antibodies to human myelin basic protein, pharmaceutical compositions and method of treatment | |
IL116559A0 (en) | Chimeric proteins | |
PT970121E (pt) | Fragmentos peptídicos de proteína básica de mielina, suas composições farmacêuticas e sua utilização no tratamento de esclerose múltipla | |
NZ335835A (en) | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |